Advances in Therapeutic Devices for Sleep Apnea (TechVision)
Technology Advances, Trends and Strategic Perspectives Reckoned to Boost the Adoption of Multiple Treatment Options
25-Jul-2016
Global
Technology Research
D711-01-00-00-00
HC02671-GL-TR_18850
The sleep apnea therapeutics market has witnessed constant growth in the last decade due to the penetration of conventional therapies in untapped regions of the world. However, it is the technological advancements that have led to the emergence of a number conventional therapies for sleep apnea treatment. Increasing patient non-compliance towards the conventional CPAP treatment has led to development of alternative treatments such as oral appliances, oral pressure therapy, neurostimulators, positional therapy devices, to name a few.This research service covers the scope of all the advancements in therapeutic devices for the treatment of sleep apnea. The research study covers the market share assessment of CPAPs, key innovators across all types of treatment devices and key drivers and challenges affecting this market.The research study further details the adoption of conventional modes of treatment in regions of North America, Europe and Asia-Pacific, explaining the healthcare structure and the likelihood of adoption of alternative treatment methods in these three regions of the world. Finally, the section on opportunity evaluation gives the reader a chance to understand the current status of the market, positioning of the newer alternatives and explore future possibilities.
1.1 Scope of Research
1.2 Research Process Methodology
1.2 Research Methodology (continued)
1.3 Key Findings
2.1 Obstructive Sleep Apnea Constitutes over 80% of the Sleep Apnea Cases
2.2 High Marked Demand for a CPAP Alternative to Treat OSA
2.3 Adoption of CPAPs Hit due to Patient Non-Compliance
2.4 Over 80% of the CPAP Market Share is Owned by Two Companies
2.5 CPAPs Expected to Dominate due to Lack of Comparative Clinical Studies
2.6 ResMed Continues to Lead the CPAP Market with Their S9 Series
2.7 Philips Respironics offers One of the Most Recent Advancements in CPAPs
2.8 CPAP Non-compliance Leads Patients to Oral Device Therapy
2.9 Oral Device Therapy is Effective in Reducing Overall Apnea Hypopnea Index
2.10 Preference Towards Oral Device Therapy Increases as it Offers a Permanent Solution
2.11 ApniCure’s Invention works on Negative Oral Pressure
2.12 SomnoMed offers the largest range of Mandibular Advancement Devices
2.13 NPD Efforts Focus on Stimulation of the Hypoglossal Nerve
2.14 Device Miniaturization Expected to Boost the Neurostimulation Segment
2.15 Nyxoah focuses on Device Miniaturization and Reduced Surgery Time
2.16 Inspire Medical Systems Presents a Targeted Neurostimulation Therapy
2.17 ImThera Medical Aims to Provide Permanent Freedom from CPAP Masks
2.18 Non-invasive Offerings Expected to Cut Down Cost of Conventional Treatments
2.19 Provent Sleep Therapy Offers a Novel Approach to Treat Obstructive Sleep Apnea
2.20 Positional Therapy from Advanced Brain Monitoring Provides a New Approach to Treat OSA
2.21 Surgical Interventions Imperative for Severe OSA Cases
2.22 Assessment of Surgery in Comparison to CPAPs and OAs
3.1 Drivers and Challenges Shaping the Sleep Apnea Treatment Market
3.2 Advancements in Technology Leading to a Rise in Alternative Therapies for OSA Treatment
3.3 Poor Patient Compliance with Conventional Therapies is the Biggest Obstacle in the Sleep Apnea Market
4.1 Reimbursements Models Need to be More Favorable Globally to Promote Adoption
4.2 North American Market Remains the Top Consumer of Sleep Apnea Therapies
5.1 ResMed and Philips Respironics Continue to Rule the CPAP Market
5.2 Inspire Medical Systems Leads the Patent Filings in the Neurostimulation Segment
5.3 Oral Appliances Witness Continued Trends in Patent Applications
5.4 Surgery Options Witness a Slow Response in Patent Filings
5.5 USA Generates Maximum Interest in Novel Technologies, as Demonstrated by the Trend in Patent Applications
6.1 Adherence Tracking is Crucial to Improve Patient Compliance with Devices
6.2 Telemedicine to Help Improve the Quality of Sleep
7.1 Global Patents
7.1 Global Patents (continued)
7.1 Global Patents (continued)
7.1 Global Patents (continued)
7.2 Key Contacts
Legal Disclaimer
8.1 The Frost & Sullivan Story
8.2 Value Proposition: Future of Your Company & Career
8.3 Global Perspective
8.4 Industry Convergence
8.5 360º Research Perspective
8.6 Implementation Excellence
8.7 Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
19 Nov 2026 | Global | Technology Research
Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms
Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.